Physician profile
Jonathan Baron
NPI 1639542673
$3,036.05
in general payments reported to CMS, 2019-2025
21 companies · $1,042 in 2025
The $1,042 reported for 2025 was more than what 81% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $283 · 2022: $946 · 2023: $394 · 2024: $372 · 2025: $1,042.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,613 · Education: $194.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,613.14 |
| Education | $193.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $1,059.83 | 2021-2024 | Axonics |
| Astellas Pharma US INC | $337.86 | 2022-2025 | Xtandi |
| Pfizer INC. | $326.45 | 2022-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $272.59 | 2021-2025 | |
| Ferring Pharmaceuticals INC. | $180.98 | 2024-2025 | Adstiladrin |
| Myovant Sciences INC. | $139.81 | 2021-2022 | |
| Endo USA, INC. | $121.09 | 2025 | Xiaflex |
| Blue Earth Diagnostics | $72.14 | 2021-2025 | Posluma |
| Sumitomo Pharma America, INC. | $67.37 | 2024-2025 | Orgovyx |
| Tolmar, INC. | $65.02 | 2024-2025 | Jatenzo, Eligard |
| Abbvie INC. | $57.96 | 2023-2025 | |
| Merck Sharp & Dohme LLC | $55.26 | 2025 | Keytruda |
| Novartis Pharmaceuticals Corporation | $51.85 | 2022-2025 | |
| Cook Medical LLC | $51.23 | 2021 | |
| Teleflex LLC | $49.24 | 2025 | Urolift, Barrigel |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioprotect Medical, INC. | $33.83 | 2025 | Bioprotect Balloon Implant System |
| Urogen Pharma, INC. | $24.92 | 2025 | |
| Dendreon Pharmaceuticals LLC | $21.88 | 2025 | Provenge |
| Myriad Genetic Laboratories, INC. | $20.45 | 2023 | Prolaris |
| Medtronic, INC. | $13.67 | 2025 | V-Loc 180 |
| Boston Scientific Corporation | $12.62 | 2025 | Axonics |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Baron listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.